Histologic and Molecular Subtype of CHEK2 and PALB2 Associated Breast Cancers

被引：0
|
作者：
Agarwal, Indu [1 ]
Sullivan, Megan E. [1 ]
机构：
[1] NorthShore Univ Hlth Syst, Evanston, IL USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
124
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [41] Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer
    Weitzel, Jeffrey N.
    Neuhausen, Susan L.
    Adamson, Aaron
    Tao, Shu
    Ricker, Charite
    Maoz, Asaf
    Rosenblatt, Margalit
    Nehoray, Bita
    Sand, Sharon
    Steele, Linda
    Unzeitig, Gary
    Feldman, Nancy
    Blanco, Amie M.
    Hu, Donglei
    Huntsman, Scott
    Castillo, Danielle
    Haiman, Christopher
    Slavin, Thomas
    Ziv, Elad
    CANCER, 2019, 125 (16) : 2829 - 2836
  • [42] Factors that differentiate cancer risk management decisions among females with pathogenic/likely pathogenic variants in PALB2, CHEK2, and ATM
    Dean, Marleah
    Tezak, Ann L.
    Johnson, Sabrina
    Weidner, Anne
    Almanza, Deanna
    Pal, Tuya
    Cragun, Deborah L.
    GENETICS IN MEDICINE, 2023, 25 (11)
  • [43] Mutational landscape of breast cancers from PALB2 germline mutation carriers
    Piscuoglio, Salvatore
    Ng, Charlotte K. Y.
    Wen, Y. Hannah
    Mannermaa, Arto
    Peterlongo, Paolo
    Tondini, Carlo
    Janatova, Marketa
    Hwang, Teo Soo
    Ng, Pei-Sze
    Looi, Lai-Meng
    Foulkes, William
    Chenevix-Trench, Georgia
    VVeigelt, Britta
    Southey, Melissa C.
    Tischkowitz, Marc
    Reis-Filho, Jorge S.
    CANCER RESEARCH, 2016, 76
  • [44] Mutational landscape of breast cancers from PALB2 germline mutation carriers
    Burke, K. A.
    Berman, S.
    Geyer, F. C.
    Piscuoglio, S.
    Ng, C. K.
    Wen, Y. H.
    Mannermaa, A.
    Peterlongo, P.
    Tondini, C.
    Janatova, M.
    Hwang, T. Soo
    Ng, P-S
    Looi, L. M.
    Chenevix-Trench, G.
    Southey, M. C.
    Weigelt, B.
    Foulkes, W.
    Tischkowitz, M.
    Reis-Filho, J. S.
    CANCER RESEARCH, 2017, 77
  • [45] CHEK2 and breast cancer risk
    Coupier, I
    Stoppa-Lyonnet, D
    BULLETIN DU CANCER, 2002, 89 (11) : 921 - 922
  • [46] CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
    Isinger, A
    Bhat, M
    Borg, A
    Nilbert, M
    BMC CANCER, 2006, 6 (1)
  • [47] Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers
    Williams, Louise H.
    Choong, David
    Johnson, Sandra A.
    Campbell, Ian G.
    CLINICAL CANCER RESEARCH, 2006, 12 (23) : 6967 - 6972
  • [48] CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
    Anna Isinger
    Misha Bhat
    Ake Borg
    Mef Nilbert
    BMC Cancer, 6
  • [49] Missense PALB2 germline variant disrupts nuclear localization of PALB2 in a patient with breast cancer
    Ming Ren Toh
    Chen Ee Low
    Siao Ting Chong
    Sock Hoai Chan
    Nur Diana Binte Ishak
    Eliza Courtney
    Arun Mouli Kolinjivadi
    Amélie Rodrigue
    Jean-Yves Masson
    Joanne Ngeow
    Familial Cancer, 2020, 19 : 123 - 131
  • [50] A PALB2 germline mutation associated with hereditary breast cancer in Italy
    Laura Papi
    Anna Laura Putignano
    Caterina Congregati
    Irene Piaceri
    Ines Zanna
    Francesco Sera
    Doralba Morrone
    Maurizio Genuardi
    Domenico Palli
    Familial Cancer, 2010, 9 : 181 - 185
12345